Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials

Journal of Neuroimmune Pharmacology

Volumn 10, Issue 2, 2015, Pages 293-301

  Lynch, M E ^a,c   Ware, Mark A ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cannabinoids; Chronic non cancer pain; Marijuana; Neuropathic pain; Systematic review

Indexed keywords

CANNABINOID; CANNABIS; FATTY ACID AMIDASE INHIBITOR; NABILONE; ANALGESIC AGENT;

ANALGESIC ACTIVITY; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CONTROLLED CLINICAL TRIAL (TOPIC); DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HEAD INJURY; HUMAN; INTERSTITIAL LUNG DISEASE; META ANALYSIS; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; ORAL SPRAY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; ANIMAL; PROCEDURES; TREATMENT OUTCOME;

ANALGESICS; ANIMALS; CANNABINOIDS; CHRONIC PAIN; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84931008318     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-015-9600-6     Document Type: Review

References (25)

1. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ (2001) Chronic pain in Australia: a prevalence study. Pain 89:127–134
2. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life and treatment. Eur J Pain 10:287–333
3. Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley BA, Gouaux B (2012) Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ 184:1143–1150
4. Cravatt BF, Demarest K, Patricelli PM, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acide amide hydrolase. Proc Natl Acad Sci 98:9371–9376
5. Finnerup NB, Sindrup SH, Jensen TS (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150:573–581
6. Huggins JP, Smart TS, Langman S, Taylor L, Young T (2012) An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain 153:1837–1846
7. Kahan M, Srivastava A, Spithoff S, Bromley L (2014) Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations. Can Fam Physician 60:1083–1090
8. Langford RM, Mares J, Novotna A, Vachova M, Novakova I, Notcutt W, Ratcliffe S (2013) A double-blind, randomised, placebo-controlled, parallel-group study of THC? CBD oralmucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. J Neurol 260:984–997
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ionnidis JPA, CLarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explanation and elaboration. Ann Int Med 15:W-65–W-94
10. Lynch ME (2008) The pharmacotherapy of chronic pain. Rheum Dis Clin N Am 34:369–385
11. Lynch ME (2011) The need for a Canadian pain strategy. Pain Res Manag 16:77–80
12. Lynch ME, Campbell F (2011) Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized controlled trials. Br J Clin Pharmacol 72:735–744
13. Lynch ME, Cesar-Rittenberg P, Hohmann AG (2014) A double-blind, placebo-controlled, corssover pilot trial with extension using oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J Pain Symptom Manag 47:166–173
14. Moulin D, Clark AJ, Speechly M, Morley-Forster P (2002) Chronic pain in Canada, prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manag 7:179–184
15. Pertwee RG (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 367:3353–3363
16. Pini LA, Guerzoni S, Cainazzo MM, Ferrari A, Sarchielli P, Tiraferri I, Ciccarese M, Zappaterra M (2012) Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. J Headache Pain 13:677–684
17. Schuelert N, Johnson MP, Oskins JL, Jassal K, Chambers MG, McDougall JJ (2011) Local application of the endocannabinoid hydrolysis inhibotor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. Pain 152:975–981
18. Serpell M, Ratcliffe S, Hovorka J, Schofield M, Taylor L, Lauder H, Ehler E (2014) A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain 18:999–1012
19. Skaper SD, DiMarzo V (2012) Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Phil Trans R Soc B 367:3193–3200
20. Toth C, Mawani S, Brady S, Chan C, Liu C, Mehina E, Garven A (2012) An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain 153:2073–2082
21. Turcotte D, Doupe M, Torabi M, Gomori A, Ethans K, Esfahani F (2014) Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial. Pain Med. doi:10.1111/pme.12569
22. Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ (2003) Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 102(1–2):211–216
23. Ware MA, FItzcharles M, Lawrence J, Shir Y (2010) The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 110:604–610
24. Wilsey B, Marcotte TD, Deutsch R, Gouaux B, Sakai S (2013) Low-dose vaporised cannabis significantly improves neuropathic pain. J Pain 14:136–148
25. Zajicek JP, Hobart JC, Slade A, Barnes D, M. PG (2012) Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry 83:1125–1132